BioNTech

BioNTech

Organization

Heard in 13 episodes across 9 shows since Aug 2026

BioNTech SE is a German biotechnology company that develops mRNA-based medicines and vaccines, including oncology immunotherapies and infectious-disease vaccines.

Discussed inMarkets100%

Episodes

13
across 9 shows

This week

0
episodes on 0 shows

Expert statements

3
1 positive · 2 negative

Share of the conversation

Mentions of BioNTech per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.

0.0‰0.02‰0.04‰0.06‰Aug 24Sep 15Oct 8Oct 30Nov 21
Show the data
DayShare (7-day)Mentions
Aug 280.03‰3
Aug 300.05‰2
Sep 130.01‰1
Sep 140.02‰1
Oct 90.01‰1
Oct 120.02‰1
Oct 160.02‰1
Oct 220.02‰1
Oct 260.02‰1
Oct 300.03‰3
Nov 170.01‰1

The full trend: rank, tone and why it is trending →

Email alert

Email me when BioNTech comes up on a podcast

One email a week at most, with the new episodes that mention BioNTech. Free, no account needed, unsubscribe in one click.

What experts have said about BioNTech

3 statements · 1 positive · 2 negative

  1. Tierney BaumNegativeNov 17, 2026· BioCentury This Week

    BioNTech and Roche’s neoantigen program has struggled to demonstrate clinical efficacy.

    “that has really struggled to show efficacy in the clinic, including as monotherapy plus Keytruda.”

    Listen at 12:54

    Open the episode · Ep. 398 - J&J’s $2B NewCo Buy, Neoantigen Vaccines, Overton Odds
  2. Tierney BaumNegativeNov 17, 2026· BioCentury This Week

    BioNTech and Roche’s Phase 3 trial failed its progression-free-survival endpoint.

    “that failed to meet its progression-free survival endpoint.”

    Listen at 13:15

    Open the episode · Ep. 398 - J&J’s $2B NewCo Buy, Neoantigen Vaccines, Overton Odds
  3. Jim CramerPositiveAug 26, 2026· Mad Money w/ Jim Cramer

    BioNTech is a good company or investment.

    “I think you got a good one.”

    Listen at 36:04

    Open the episode · Mad Money w/ Jim Cramer 8/26/26

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Episodes

13 episodes featuring BioNTech, newest first